Stomach Cancer Trial, Recruiting NCT06690112 Sponsor: Gangnam Severance Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06690112
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with stomach (gastric) adenocarcinoma confirmed by a tissue test before surgery.
  • Your surgeon believes your cancer can be completely removed during surgery.
  • You have been assessed as fit enough for surgery, with an anesthesia risk score of 3 or below (on a standard 5-point scale used by anesthesiologists).
  • After surgery, the drain tube placed in your abdomen is collecting more than 300 ml (about 1¼ cups) of fluid in a 24-hour period on the 4th day after your operation.

Who may not be able to join:

  • You are 80 years old or older.
  • Your stomach cancer has been classified as stage IV (most advanced stage).
  • You have fluid build-up in your abdomen caused by cancer spreading to the lining of the abdomen (peritoneal metastasis).
  • You have developed clear complications inside your abdomen after surgery.
  • You need an additional drain inserted through the skin because your current drain is not working well enough.
  • Your surgery did not remove all visible cancer (incomplete removal was performed).
  • You have been diagnosed with a cancer other than stomach cancer.
  • You have had a major abdominal surgery or radiation treatment to the abdomen in the past that may affect how your body absorbs fluid inside the abdomen (confirm with trial site).
  • Your drain is collecting more than 500 ml (about 2 cups) of fluid in a 24-hour period on the 4th day after surgery.
  • You have any of the following signs or conditions after surgery: a leak from the pancreas detected through drain fluid tests; a fever above 37.8°C (100°F); significantly elevated infection markers in your blood (high white blood cell count or high C-reactive protein); or drain fluid that is milky-colored, bloody, or looks like there may be ongoing internal bleeding.
  • Certain groups of people are not eligible to participate, including anyone under 18, pregnant women, newborns, adults who cannot give informed consent, people living in institutional facilities, students, employees of hospitals or research centers, pharmaceutical company employees, military personnel, unemployed people, people experiencing financial hardship, homeless individuals, people who are terminally ill, or people in emergency situations.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 82-2-2019-4601

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gangnam Severance Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
30 June 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Incidence of Intra-Abdominal Complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov